Current trends and outcomes of surgical treatment of colorectal cancer with liver metastasis

Aim. To analyze multimodal treatment outcomes in patients with liver metastases from colorectal cancer, who were treated at multidisciplinary cancer clinic. Material and methods. From 2007 to 2021, 315 colorectal cancer patients with liver metastases underwent liver resections (201, 63.8 %), radiofrequency ablation (RFA) (29, 9.2 %), microwave ablation (MWA) (22, 6.9 %), transarterial chemoembolozation (TACE) in combination with RFA (22, 6.9 %), and TACE + RFA + TACE combination (41, 13.2 %) at the department of liver and pancreas surgery, Moscow Botkin Clinical Hospital. Results. A 90-day mortality rate was 1.9% in 6 patients who underwent liver resection. Postoperative complications after liver resection were observed in 49 patients (24.3 %). The overall 5- and 10-year survival rates after liver resection were 38.8 % and 23.2 %, respectively. The factors of poor prognosis after liver resection were: age over 70 years (p=0.03), localization of the primary tumor in the right half or rectum (p=0.037), three or more metastatic foci in the liver (p=0.01), maximum size of the tumor of more than 5 cm (p=0.021), synchronous colorectal liver metastases (p=0.039), and bilobar colorectal liver metastases (p=0.007). Postoperative complications after RFA, TACE + RFA, TACE + RFA + TACE WERE 5.8 %, 9.1 % and 7.3 %, respectively. In patients with a size of metastases of no more than 3 cm, the 3-year disease-free and overall survival rates after rfa were 45.8 % and 54.2 %, respectively. In patients with a size of metastases from 3 to 5 cm, the 3-year disease-free and overall survival rates after TACE + RFA + TACE were 56.1 % and 63.4 %, respectively. Conclusion. In colorectal cancer patients with liver metastases, multimodal treatment within a multi-disciplinary setting demonstrated significant improvements in their survival.

1. Moris D., Ronnekleiv-Kelly S., Rahnemai-Azar A.A., Felekouras E., Dillhoff M., Schmidt C., Pawlik T.M. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. J Gastrointest Surg. 2017; 21(6): 1076–85. doi: 10.1007/s11605-017-3397-y.

2. Efanov M., Alikhanov R., Tsvirkun V., Kazakov I., Melekhina O., Kim P., Vankovich A., Grendal K., Berelavichus S., Khatkov I. Comparative analysis of learning curve in complex robot-assisted and laparoscopic liver resection. HPB (Oxford). 2017; 19(9): 818–24. doi: 10.1016/j.hpb.2017.05.003.

3. Granov D.A., Polikarpov A.A., Sergeev V.I., Tarazov P.G. Preoperative Portal Vein Embolization and Hepatic Arterial Chemoembolization in the Combined Treatment of Patients with Liver Malignancies. Annals of HPB Surgery. 2016; 21(3): 20–4. (in Russian). doi: 10.16931/1995-5464.2016320-24.

4. Kulikova N., Kulezneva Yu., Melekhina O., Alikhanov R., Efanov M. Immediate outcomes of percutaneous radiofrequency-assisted liver partition and portal vein embolization for staged hepatectomy (PRALPPS) in patients with intrahepatic cholangiocarcinoma (IHCC). Annals of Hepato-Biliary-Pancreatic Surgery. 2021; 25(1): 190. doi: 10.14701/ahbps.LV-PP-3-3.

5. Chzhao A.V., Vishnevsky V.A., Ionkin D.A., Olifir A.A., Ayvazyan X.A., Kovalenko Yu.A., Zhavoronkova O.I., Stepanova Yu.A., Karelskaya N.A. The choice of local destruction method of colorectal cancer liver metastases. Annals of HPB Surgery. 2019; 24(4): 30–6. (in Russian). doi: 10.16931/1995-5464.2019430-36.

6. Shabunin A.V., Tavobilov M.M., Grekov D.N., Drozdov P.A. Combined modality treatment for patients with inoperable colorecral liver metastases. Siberian Journal of Oncology. 2018; 17(3): 34–40. (in Russian). doi: 10.21294/1814-4861-2018-17-3-34-40.

7. Borakati A., Froghi F., Shetye A., Fusai G.K., Davidson B.R., Mirnezami R. Assessing the Impact of Primary Tumour Location on Survival After Resection of Colorectal Liver Metastases: A Propensity Weighted Retrospective Cohort Study. World J Surg. 2022; 46(7): 1734–55. doi: 10.1007/s00268-022-06514-z.

8. Shabunin A.V., Parfenov I.P., Bedin V.V., Grekov D.N., Tavobilov M.M., Drozdov P.A., Karpov A.A., Zhuravel O.S., Ozerova D.S. Comparison of parenchymasaving and extensive resections in the treatment of patients with metastasis of colorectal cancer to the liver. Bulletin of Surgical Gastroenterology. 2019; (1): 42–9. (in Russian).

9. Dobrodeev A.Y., Kostromitsky D.N., Afanasyev S.G., Tarasova A.S., Avgustinovich A.V. Modern approaches to surgical treatment of patients with colorectal cancer liver metastases. Annals of HPB Surgery. 2022; 27(1): 80–6. (in Russian). doi: 10.16931/1995-5464.2022-1-80-86.

10. Shabunin A.V., Parfenov I.P., Bedin V.V., Tavobilov M.M., Grekov D.N., Karpov A.A. Specific complications of liver resection and their prevention. Pirogov Russian Journal of Surgery. 2020; (3): 5–12. (in Russian). doi: 10.17116/hirurgia20200315.

11. Mulier S., Ni Y., Jamart J., Ruers T., Marchal G., Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate metaanalysis and review of contributing factors. Ann Surg. 2005; 242(2): 158–71. doi: 10.1097/01.sla.0000171032.99149.fe.